World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
22481
World Ranking
16226
National Ranking
613

Overview

P.A. van Doorn is affiliated with Erasmus University Rotterdam in the Netherlands and conducts research primarily in the fields of Medicine and Neuroscience. Their work focuses on subfields such as Neurology and Cellular and Molecular Neuroscience.

The scientist's research topics include:

  • Hereditary Neurological Disorders
  • Peripheral Neuropathies and Disorders
  • Long-Term Effects of COVID-19

Van Doorn's recent publications reflect these research interests. Notable papers include:

  • COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associations (2020) published in Brain
  • Ausmaß des Ansprechens auf subkutanes (s. c.) Efgartigimod PH20 bei chronischer entzündlicher demyelinisierender Polyneuropathie (CIDP): Die Studien ADHERE/ADHERE+ (2025) published in Nervenheilkunde

The scientist has collaborated with several peers, with frequent co-authors including:

  • Luís Querol
  • Michael P. Lunn
  • David R. Cornblath
  • Bart C. Jacobs
  • Richard AC Hughes

Van Doorn's work appears primarily in venues such as Brain and Nervenheilkunde, each contributing to the dissemination of findings relevant to neurological conditions and treatments.

Best Publications

  • European Federation of Neurological Societies/Peripheral Nerve Society Guideline on Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision

    P. Y. K. Van den Bergh;R. D. M. Hadden;P. Bouche;D. R. Cornblath

  • The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study

    B. C. Jacobs;P. H. Rothbarth;F.G.A. van der Meché;P. Herbrink

  • PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

    G Francis;R Hughes;J King;P Mitchell

  • Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy

    R Hughes;Peter Van den Bergh;S Bensa;H Willison

  • Prospective study on the relationship between infections and multiple sclerosis exacerbations

    D. Buljevac;H. Z. Flach;W. C. J. Hop;D. Hijdra

  • Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human -Glucosidase From Milk

    M. Christa;B. Loonen;Arnold G. Vulto;Adri Cromme-Dijkhuis

  • Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients

    M. L. C. Hagemans;L. P. F. Winkel;P. A. Van Doorn;W. J. C. Hop

  • Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial.

    R van Koningsveld;Pim Schmitz;Fga van der Meché;LH Visser

  • Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners.

    A. C. J. W. Janssens;P. A. van Doorn;J. B. de Boer;F. G. A. van der Meché

  • Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.

    I S J Merkies;P I M Schmitz;F G A van der Meché;J P A Samijn

  • Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies

    S.I. van Nes;E.K. Vanhoutte;P.A. van Doorn;M. Hermans

  • High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.

    P.A. van Doorn;A. Brand;P.F.W. Strengers;J. Meulstee

  • Distinguishing acute-onset CIDP from fluctuating Guillain-Barré syndrome A prospective study

    L. Ruts;J. Drenthen;B. C. Jacobs;P. A. van Doorn

  • EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.

    I. Elovaara;S. Apostolski;P. Van Doorn;N. E. Gilhus

  • Fatigue in immune-mediated polyneuropathies

    I. S. J. Merkies;P. I. M. Schmitz;J. P. A. Samijn;F. G. A. van der Meche

  • Early recognition of poor prognosis in Guillain-Barré syndrome

    C. Walgaard;H.F. Lingsma;L. Ruts;P.A. van Doorn

  • Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group

    I S J Martina;R van Koningsveld;P I M Schmitz;F G A van der Meché

  • European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy : report of a joint task force of the European federation of neurological societies and the peripheral nerve society

    R A C Hughes;P Bouche;D R Cornblath;E Evers

  • Diagnostic and classification criteria for the Guillain-Barré syndrome.

    F.G.A. van der Meché;P.A. van Doorn;J. Meulstee;F.G.I. Jennekens

  • Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.

    M. Vermeulen;P. A. Van Doorn;A. Brand;P. F. W. Strengers

Frequent Co-Authors

Wim C. J. Hop
Wim C. J. Hop Erasmus University Rotterdam
Marinus Vermeulen
Marinus Vermeulen University of Amsterdam
Bart C. Jacobs
Bart C. Jacobs Erasmus University Rotterdam
Anneke Brand
Anneke Brand Leiden University Medical Center
Jon D. Laman
Jon D. Laman University Medical Center Groningen
B.G.M. van Engelen
B.G.M. van Engelen Radboud University
Richard A. C. Hughes
Richard A. C. Hughes University College London
David R. Cornblath
David R. Cornblath Johns Hopkins University School of Medicine
Hubert P. Endtz
Hubert P. Endtz Erasmus University Rotterdam
Claudia Sommer
Claudia Sommer University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open new opportunities if you're considering a flexible route to a medical career. One popular option is the rn to bsn online without clinicals program. These allow registered nurses to advance their education without the need for additional clinical placements, making it more accessible for working professionals.

For those aiming for leadership roles, advanced practice, or teaching in nursing, accelerated dnp programs offer a fast-track to the highest level of clinical nursing education. Budget-conscious students may also consider cheapest online dnp programs that make earning a Doctor of Nursing Practice degree more affordable.

If you're just starting your healthcare journey, online lpn programs provide a streamlined path to becoming a Licensed Practical Nurse. These programs are ideal for those seeking quick entry into the healthcare workforce with the flexibility of online study.

Whether you're advancing your career or starting out, these online pathways offer convenient and cost-effective options aligned with your goals in the medical field.

Best Scientists Citing P.A. van Doorn

Trending Scientists

Recently Published Articles